Acrivon Therapeutics' Incubator/Accelerator Round

Acrivon Therapeutics raised a round of funding on May 07, 2018. Investors include LabCentral.

Acrivon Therapeutics is a biotech company specializing in drug development through early clinical treatment success using our unique predictive biomarker approach.…

Articles about Acrivon Therapeutics' Incubator/Accelerator Round: